Clinical Trials Browser

Phase 2 × dalpiciclib × Gynecologic × Clear all

NCT06552858 2024-08-14

Fluzoparib Combined With Dalpiciclib for Platinum Resistant Recurrent Ovarian Cancer

Phase 2 Not yet recruiting

Ovarian Neoplasms

NCT06243185 2024-02-06

Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid Tumors

Phase 2 Unknown

Ovarian Neoplasms